Long COVID's Root Cause: Oxidative Stress — What New Research Shows

The Study That Changed the Conversation

In late 2025, researchers published a study in the Proceedings of the National Academy of Sciences (PNAS) — one of the most prestigious peer-reviewed journals in the world — that provided some of the clearest molecular evidence to date for what is actually going wrong inside Long COVID patients' bodies.

The study, identified by DOI 10.1073/pnas.2426564122, analyzed lymphocytes — a class of immune cells — drawn from Long COVID and ME/CFS patients. What researchers found was consistent and striking: the cells showed measurable excess production of reactive oxygen species (ROS), visible signs of mitochondrial structural damage, and significantly depleted antioxidant defense systems compared to healthy controls.

This was not the first study to raise the possibility. But a PNAS publication carries particular weight: it undergoes rigorous peer review, draws broad scientific readership, and its findings typically land in the top 1% of cited research within their field. When PNAS confirms something, the scientific community pays attention.

The implication is significant. If oxidative stress is a shared, measurable hallmark of Long COVID and ME/CFS — not just a side effect, but a core driver — then the path to meaningful symptom management may run directly through antioxidant biology.

65 Million People. The Same Three Symptoms.

The World Health Organization estimates that more than 65 million people worldwide are living with Long COVID — broadly defined as persistent symptoms lasting more than 12 weeks after a SARS-CoV-2 infection. ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), which researchers now recognize as a closely related condition that Long COVID can trigger or mimic, affects millions more.

Across both conditions, three symptoms dominate nearly every patient survey:

• Fatigue — not ordinary tiredness, but a bone-deep exhaustion unrelieved by sleep, reported by over 80% of Long COVID patients.
• Brain fog — difficulty concentrating, memory problems, and slowed cognitive processing, reported in over 60% of cases.
• Post-exertional malaise (PEM) — a worsening of all symptoms following even minimal physical or mental exertion, which is considered the hallmark feature of ME/CFS and a defining feature of severe Long COVID.

All three of these symptoms map directly onto what we know about mitochondrial ROS damage. The mitochondria are the energy-producing organelles inside every cell. When ROS overwhelms their defense systems, energy output collapses, neural signaling degrades, and the threshold for cellular stress drops dramatically — creating exactly the pattern of fatigue, cognitive impairment, and exertional intolerance that Long COVID patients describe.

What Reactive Oxygen Species Actually Do Inside Cells

Reactive oxygen species are not inherently harmful — in small amounts, they are normal byproducts of cellular metabolism and play important roles in immune signaling. The problem arises when their production exceeds the cell's antioxidant capacity. This state, called oxidative stress, leads to a cascade of cellular damage that now sits at the center of Long COVID biology.

The PNAS 2025 study identified two specific ROS species as particularly elevated in Long COVID lymphocytes: the hydroxyl radical (•OH) and peroxynitrite (ONOO⁻). These are among the most reactive and damaging molecular species in biology. The hydroxyl radical, in particular, reacts with almost anything it contacts — lipids, proteins, DNA — at near-diffusion-limited speed, meaning it damages its target before cellular defenses have any chance to intercept.

A parallel body of research on microinflammation (see PMC11413900) has traced how persistent low-grade inflammation following viral infection sustains this elevated ROS state, keeping mitochondria under continuous oxidative load even months after the initial infection has resolved. This may help explain why Long COVID does not simply resolve with time for so many patients.

Why Molecular Hydrogen Is Uniquely Positioned Among Antioxidants

Most antioxidants work by donating electrons to neutralize free radicals. The problem is delivery: many antioxidants are too large or too charged to efficiently penetrate the mitochondrial membrane — the site where Long COVID-related ROS is generated. Vitamin C (molecular weight: 176 daltons) and NAC (163 daltons) must be converted by the body before their active components can reach mitochondrial compartments, and even then, delivery is indirect.

Molecular hydrogen (H2) is a gas with a molecular weight of just 2 daltons. It is the smallest molecule in nature. This size advantage allows H2 to pass freely through cell membranes, across the blood-brain barrier, and directly into the mitochondrial matrix — without any conversion or carrier mechanism required.

The original 2007 paper by Ohsawa et al. in Nature Medicine (PMID 17704779) established that H2 selectively reacts with and neutralizes hydroxyl radicals (•OH) and peroxynitrite — the exact species identified as elevated in Long COVID — while leaving beneficial ROS (such as superoxide used in immune signaling) intact. This selectivity is a key differentiator: many broad-spectrum antioxidants suppress all ROS indiscriminately, potentially blunting immune function. H2 does not.

When dissolved in water at concentrations achievable through SPE/PEM electrolysis, molecular hydrogen can be consumed as hydrogen-rich water, delivering H2 systemically within minutes of ingestion.

The Active Clinical Trial You Should Know About

Beyond the mechanistic evidence, there is active clinical investigation underway. Trial NCT07009691, registered with the U.S. National Institutes of Health, is currently testing hydrogen-rich water as an intervention for ME/CFS — using heart rate variability (HRV) as a primary biomarker of autonomic nervous system function and recovery capacity.

The choice of HRV as a biomarker is clinically meaningful. HRV is a well-validated measure of the balance between sympathetic and parasympathetic nervous system activity. In both ME/CFS and Long COVID, HRV is typically reduced — a sign of autonomic dysregulation that tracks closely with symptom severity. A hydrogen water intervention that improves HRV would suggest a real impact on the underlying physiology, not just subjective symptom reporting.

This trial represents exactly the kind of evidence-building that the field needs, and its existence signals growing mainstream scientific interest in molecular hydrogen as a tool for post-viral recovery research.

What This Means in Practical Terms — And What It Does Not

It is important to be clear about the limits of current evidence. The 2025 PNAS study demonstrates a mechanism — elevated oxidative stress — that hydrogen water's chemistry is theoretically well-suited to address. The systematic review in PMC10816294 supports the biological plausibility of H2 interventions for conditions characterized by oxidative stress. But a completed large-scale randomized controlled trial specifically in Long COVID patients does not yet exist.

Hydrogen water is not a treatment for Long COVID or ME/CFS. Nothing in this article should be construed as medical advice. If you are experiencing Long COVID symptoms, the appropriate first step is to work with a physician — ideally one familiar with post-viral illness — to develop a comprehensive care plan.

That said, hydrogen-rich water sits in an unusual position among potential supportive options: its safety profile is exceptionally well-documented (zero adverse events across all human trials to date), its mechanism aligns precisely with what the PNAS 2025 finding identifies as the core problem, and it carries no known drug interactions that would make it inappropriate to add alongside conventional care.

For people living with Long COVID who are already managing their condition under medical supervision and are exploring supportive strategies, the science now offers a more informed basis for understanding what role antioxidant biology might play in that picture.

Where the Research Goes From Here

The field is moving quickly. The PNAS 2025 publication has already prompted discussion across Long COVID research networks about the value of antioxidant-targeting interventions in clinical trials. The ME/CFS hydrogen water trial (NCT07009691) is expected to generate data that will either strengthen or qualify the current mechanistic case.

Researchers are also looking more closely at how oxidative stress interacts with other Long COVID pathways — including viral persistence, autoimmunity, and microbiome disruption — to understand whether antioxidant support needs to be part of a multi-pronged approach rather than a standalone strategy.

What is now beyond serious scientific debate is that oxidative stress is not a peripheral feature of Long COVID — it is central. That clarity changes what questions researchers ask, what interventions get studied, and ultimately what options become available to the tens of millions of people who need them.